Drug
Hrs 2129
Hrs 2129: highest development phase Phase 2/3, developed by Shandong Suncadia Medicine Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Shandong Suncadia Medicine Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| HRS-2129 Tablets NCT07185594 | Phase 2/3 | Postoperative Analgesia |
Latest
No recent events.
Follow Hrs 2129 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.